AstraZeneca’s U.S. trial shows vaccine is 79 percent effective

The U.S. trial included 32,000 volunteers and is a boost for the troubled vaccine, which had its rollout paused across Europe last week after reports of a relative handful of rare but worrying blood clots.
Source